Literature DB >> 3129486

Serum vitamin D metabolites do not change in response to intravenous injection of thyrotropin releasing hormone (TRH) and growth hormone releasing factor (GHRF 1-44) in children.

R Rosskamp1, S Issa, W Burmeister.   

Abstract

Several reports claim that thyroid hormones and growth hormone participate in the regulation of vitamin D synthesis. We investigated whether there was a direct effect of their releasing hormones on vitamin D metabolism. TRH (7 micrograms/kg) was injected iv in 8 children with euthyroid diffuse goiter and GHRF (1 microgram/kg) in 10 short normal children. TRH injection induced significant TSH elevations but no changes in serum vitamin D metabolites, calcium and phosphorus. GHRF administration resulted in marked growth hormone elevations without alterations in the serum vitamin D metabolites, calcium and phosphorus. These results indicate no direct effect of TRH or GHRF itself on vitamin D metabolism, as well as a lack of very short term effect of growth hormone and TSH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129486     DOI: 10.1007/BF03350090

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  1 alpha, 25-Dihydroxyvitamin D3 nuclear receptors in pituitary.

Authors:  H A Gelbard; P H Stern; D C U'Prichard
Journal:  Science       Date:  1980-09-12       Impact factor: 47.728

2.  Effects of vitamin D3 metabolites on production of prolactin and growth hormone in rat pituitary cells.

Authors:  E Haug; J I Pedersen; K M Gautvik
Journal:  Mol Cell Endocrinol       Date:  1982-09       Impact factor: 4.102

3.  Rapid changes in serum vitamin D metabolites in response to TRH.

Authors:  K Kano
Journal:  Horm Metab Res       Date:  1984-10       Impact factor: 2.936

4.  Biochemical evidence for 1,25-dihydroxyvitamin D receptor macromolecules in parathyroid, pancreatic, pituitary, and placental tissues.

Authors:  J W Pike; L L Goozé; M R Haussler
Journal:  Life Sci       Date:  1980-02-04       Impact factor: 5.037

5.  Does 1,25-dihydroxyvitamin D participate in the regulation of hormone release from endocrine glands?

Authors:  Z Hochberg; Z Borochowitz; A Benderli; P Vardi; S Oren; Z Spirer; I Heyman; Y Weisman
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958

6.  Parathyroid function and vitamin D metabolism during human growth hormone replacement.

Authors:  J M Gertner; R L Horst; A E Broadus; H Rasmussen; M Genel
Journal:  J Clin Endocrinol Metab       Date:  1979-08       Impact factor: 5.958

7.  Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism.

Authors:  B Jastrup; L Mosekilde; F Melsen; B Lund; B Lund; O H Sørensen
Journal:  Metabolism       Date:  1982-02       Impact factor: 8.694

8.  Thyrotropes in the pituitary are target cells for 1,25 dihydroxy vitamin D3.

Authors:  M Sar; W E Stumpf; H F DeLuca
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

9.  Receptor for 1,25-dihydroxyvitamin D3 in GH3 pituitary cells.

Authors:  M R Haussler; S C Manolagas; L J Deftos
Journal:  J Steroid Biochem       Date:  1982-01       Impact factor: 4.292

10.  Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3.

Authors:  R Bouillon; E Muls; P De Moor
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.